← Open Payments lookup

REBEKAH AMIS: Open Payments

NPI 1669065801 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$509 in 19 payments from 8 companies in 2025. Trend: 2023 $291 · 2024 $174 · 2025 $509

Food & beverage: $509
CompanyPaymentsAmount
Organon LLC2$137
Astellas Pharma US Inc5$116
MAYNE PHARMA COMMERCIAL LLC3$78
Sumitomo Pharma America, Inc.3$58
Evofem Biosciences, Inc.2$35
Bayer Healthcare Pharmaceuticals Inc.2$33
MILLICENT US INC1$28
Biogen, Inc.1$26

Products named: Veozah, MYFEMBREE, Phexxi, INTRAROSA, NEXPLANON, ZURZUVAE, GEMTESA, Mirena.

Industry payments across GA — which companies pay providers there.